Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Validation of a clinical prognostic model to identify low‐risk patients with pulmonary embolism
2007
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Elevated Heart-Type Fatty Acid-Binding Protein Levels on Admission Predict an Adverse Outcome in Normotensive Patients With Acute Pulmonary Embolism
2010
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
2010 Standout
Prospective Evaluation of Right Ventricular Function and Functional Status 6 Months After Acute Submassive Pulmonary Embolism
2009
Perioperative Management of Antithrombotic Therapy
2012 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
A Clinical Prediction Rule for Identifying Short-Term Risk of Adverse Events in Patients With Pulmonary Thromboembolism
2007
Prevention of VTE in Nonsurgical Patients
2012 Standout
Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism
2007
Outcome in Stable Patients With Acute Pulmonary Embolism Who Had Right Ventricular Enlargement and/or Elevated Levels of Troponin I
2010
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Executive Summary
2012 Standout
Biomarker-based risk assessment model in acute pulmonary embolism
2005
Prognostic Role of Echocardiography Among Patients With Acute Pulmonary Embolism and a Systolic Arterial Pressure of 90 mm Hg or Higher
2005
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism
2008
Pulmonary thromboembolic disease spectrum: diagnostic and therapeutic strategies
2009
Pulmonary Hypertension Affects Left Ventricular Basal Twist: A Novel Use for Speckle‐Tracking Imaging
2008
Enlarged Right Ventricle Without Shock in Acute Pulmonary Embolism: Prognosis
2008
Pulmonary Embolism: Prognostic CT Findings
2007
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up
2009
Prospective validation of the Pulmonary Embolism Severity Index
2008
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism*
2006
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Derivation and Validation of a Prognostic Model for Pulmonary Embolism
2005
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Escala de riesgo de eventos adversos a corto plazo en pacientes con tromboembolia pulmonar
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Defining normal variables of right ventricular size and function in pulmonary hypertension: an echocardiographic study
2008
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
2016
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Works of Elske Quak being referenced
Prognostic Value of Echocardiographically Assessed Right Ventricular Dysfunction in Patients With Pulmonary Embolism
2004